| Current Price | $1.99 | Mkt Cap | $114.2M |
|---|---|---|---|
| Open | $1.95 | P/E Ratio | 0.00 |
| Prev. Close | $1.99 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.93 - $2.02 | Volume | 1,111,220 |
| 52-Wk Range | $0.94 - $2.21 | Avg. Daily Vol. | 1,003,690 |
A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.
| Current Price | $1.99 | Mkt Cap | $114.2M |
|---|---|---|---|
| Open | $1.95 | P/E Ratio | 0.00 |
| Prev. Close | $1.99 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.93 - $2.02 | Volume | 1,111,220 |
| 52-Wk Range | $0.94 - $2.21 | Avg. Daily Vol. | 1,003,690 |
The best Bull and Bear pitches based on recency and number of recommendations.
It is outperforming the market. Volume low. Nobody is panicking.
Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.
Read the most recent pitches from players about PLX.
Recs
Paul8888888
(< 20)
Submitted: 1/23/2016 2:31:12 PM :
Start Price:
$0.86
NYSE MKT:PLX Score:
+22.74
It is outperforming the market. Volume low. Nobody is panicking.
Recs
SqwiiTrader
(< 20)
Submitted: 11/5/2013 2:56:24 PM :
Start Price:
$4.40
NYSE MKT:PLX Score:
-178.43
IHS pattern
Recs
TMFBiologyFool
(70.76)
Submitted: 5/2/2012 12:24:24 PM :
Start Price:
$7.02
NYSE MKT:PLX Score:
+253.41
Low patient numbers + 2 competitors = tough launch.
I actually like the manufacturing technology, but next drug is still years away.
Find the members with the highest scoring picks in PLX.
midastouch017 (< 20) Score: +735.37
For those who believe the biosimilar sector will enjoy a robust bright future, PLX is a wise bet
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| 1or5stars | 98.66 | 2/10/2009 |
|
3W | $2.66 | -24.81% | +366.34% | +391.15 | 0 Comment | |
| anticitradeshort | 26.79 | 4/20/2009 |
|
NS | $2.27 | -11.89% | +366.98% | +378.88 | 0 Comment | |
| Spelunkin | 26.20 | 11/3/2009 |
|
5Y | $10.39 | -80.75% | +281.09% | +361.84 | 0 Comment | |
| anticitrademix2 | < 20 | 11/2/2009 |
|
5Y | $9.90 | -79.80% | +279.66% | +359.46 | 0 Comment | |
| anticitrademix | < 20 | 11/2/2009 |
|
5Y | $9.90 | -79.80% | +279.66% | +359.46 | 0 Comment | |
| MSFOBV1YH | 95.10 | 11/4/2009 |
|
5Y | $10.93 | -81.70% | +274.69% | +356.40 | 0 Comment | |
| TrackDuality | < 20 | 11/6/2009 |
|
5Y | $11.89 | -83.18% | +272.05% | +355.23 | 0 Comment | |
| ModernDayWarrior | 28.28 | 10/29/2009 |
|
5Y | $9.58 | -79.12% | +275.83% | +354.96 | 0 Comment | |
| mathieugp | 26.14 | 9/28/2009 |
|
3M | $7.87 | -74.59% | +277.05% | +351.64 | 0 Comment | |
| 39272x4 | < 20 | 11/9/2009 |
|
5Y | $12.00 | -83.33% | +266.23% | +349.56 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
